Skip to content

Author

David A. Mei

We have 3 of 84 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Controversy: Anticoagulants need to be maintained after catheter ablation of atrial fibrillation in patients at risk of stroke-Pro and Contra.

The pillars of atrial fibrillation (AF) management include stroke prevention, patient-centred symptom directed decisions on rhythm or rate control, and the proactive management of comorbidities and lifestyle changes. These pillars are not in isolation; they are complementary to each other. While oral anticoagulants (OA...

G. Boriani, S. Boveda, David A. Mei et al. · 0 citations
Open access Sep 2026

Yield of Atrial Fibrillation Screening according to Methodology and Patient Characteristics: An Individual Participant Data Meta-Analysis of 34,165 Individuals Screened for Atrial Fibrillation within the AFFECT-EU/AF-SCREEN Collaboration.

The findings support tailoring the screening approach to the individual target population in clinical practice, and were independently associated with greater AF detection, particularly in those having single-timepoint screening.

L. Y. Xing, W. F. McIntyre, J. Engdahl et al. · 0 citations
Review Open access Aug 2026

From Algorithm Development to Clinical Implementation: A Systematic Review of Artificial Intelligence in Cardiovascular Medicine

Although AI demonstrated promising diagnostic and prognostic performance across multiple cardiovascular conditions, most applications remain at the validation stage, and future research should prioritise implementation science, pragmatic evaluation, and real-world evidence to facilitate routine adoption and maximise pa...

Lucía Osoro, E. Arbelo, D. Lane et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.